Literature DB >> 12548550

INI1 expression induces cell cycle arrest and markers of senescence in malignant rhabdoid tumor cells.

Britta S Reincke1, Gary B Rosson, Betty W Oswald, Cynthia F Wright.   

Abstract

The INI1 gene, which encodes a functionally uncharacterized protein component of the hSWI/SNF chromatin remodeling complex, is often mutated or deleted in malignant rhabdoid tumor (MRT). Two isoforms of INI1, that differ by the variable inclusion of nine amino acids, potentially are produced by differential RNA splicing. To determine the effect of the two INI1 isoforms on cell growth, INI1-devoid (MRT) and INI1-expressing cell lines were transfected separately with mammalian expression vectors or transduced with adenoviruses. Transfection of the short form of INI1 into either INI1-deficient or expressing cell lines resulted in complete suppression of cell growth in colony formation assays. The longer splice variant induced moderate to severe growth suppression of MRT cells, but had a far milder effect on non-MRT cells. Transduction of MRT cells with adenoviruses expressing either isoform of INI1 led to a dramatic change in morphology, growth suppression, and cell cycle arrest. Furthermore, senescence-associated proteins were up-regulated after transduction, while levels of proteins implicated in cell cycle progression were down-regulated. Adenoviral delivery of INI1 into a non-MRT cell line, however, had no demonstrable effect on any of these parameters. These results support the genetic evidence that INI1 is a tumor suppressor gene gone awry in MRT cells, and also suggest that delivery of the INI1 gene to MRT cells by adenoviruses may lead to a more effective treatment of this highly aggressive malignancy. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12548550     DOI: 10.1002/jcp.10201

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  15 in total

1.  The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene.

Authors:  Li Wang; Robert A Baiocchi; Sharmistha Pal; George Mosialos; Michael Caligiuri; Saïd Sif
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

2.  Malignant rhabdoid tumor in a pregnant adult female: literature review of central nervous system rhabdoid tumors.

Authors:  Michelle L Erickson; Randall Johnson; Serguei I Bannykh; Alain de Lotbiniere; Jung H Kim
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

3.  The SWI/SNF chromatin-remodeling complex subunit SNF5 is essential for hepatocyte differentiation.

Authors:  Lionel Gresh; Brigitte Bourachot; Andreas Reimann; Bruno Guigas; Laurence Fiette; Serge Garbay; Christian Muchardt; Louis Hue; Marco Pontoglio; Moshe Yaniv; Agnès Klochendler-Yeivin
Journal:  EMBO J       Date:  2005-09-01       Impact factor: 11.598

4.  Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism.

Authors:  Yasumichi Kuwahara; Aubri Charboneau; Erik S Knudsen; Bernard E Weissman
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

5.  SNR1 (INI1/SNF5) mediates important cell growth functions of the Drosophila Brahma (SWI/SNF) chromatin remodeling complex.

Authors:  Claudia B Zraly; Daniel R Marenda; Andrew K Dingwall
Journal:  Genetics       Date:  2004-09       Impact factor: 4.562

6.  SNF5/INI1 deficiency redefines chromatin remodeling complex composition during tumor development.

Authors:  Darmood Wei; Dennis Goldfarb; Shujie Song; Courtney Cannon; Feng Yan; Donastas Sakellariou-Thompson; Michael Emanuele; Michael B Major; Bernard E Weissman; Yasumichi Kuwahara
Journal:  Mol Cancer Res       Date:  2014-07-09       Impact factor: 5.852

7.  SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters.

Authors:  Yasumichi Kuwahara; Darmood Wei; Joel Durand; Bernard E Weissman
Journal:  Mol Cancer Res       Date:  2013-01-30       Impact factor: 5.852

8.  Dependence on PI3K/Akt signaling for malignant rhabdoid tumor cell survival.

Authors:  Kristen Foster; Yong Wang; Daohong Zhou; Cynthia Wright
Journal:  Cancer Chemother Pharmacol       Date:  2008-07-19       Impact factor: 3.333

9.  Surgery and actinomycin improve survival in malignant rhabdoid tumor.

Authors:  Ryan Horazdovsky; J Carlos Manivel; Edward Y Cheng
Journal:  Sarcoma       Date:  2013-02-03

10.  Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors.

Authors:  Elizabeth M Algar; Andrea Muscat; Vinod Dagar; Christian Rickert; C W Chow; Jaclyn A Biegel; Paul G Ekert; Richard Saffery; Jeff Craig; Ricky W Johnstone; David M Ashley
Journal:  PLoS One       Date:  2009-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.